Centricity Research Pointe-Claire Multispecialty

Pointe-Claire, Quebec H9R 4S3

0 studies enrolling now · 1 studies all time

What they study most

Obesity, Overweight

Studies at this site

• A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes — Withdrawn before enrolling